A new tool seeks to educate docs about Parkinson's symptoms

The device could be used by physicians to better understand the severity of a patient's symptoms and elicit empathy.

In Merck video, woman says a cure is the greatest invention

In Merck video, woman says a cure is the greatest invention

The drugmaker's video asks people in New York and San Francisco about their ideas for great inventions.

5 of healthcare's hardest nuts to crack

5 of healthcare's hardest nuts to crack

How are pharma, clinical, and startup execs addressing some of the biggest challenges facing their businesses today?

Read the complete April 2017 digital edition

Read the complete April 2017 digital edition

Here you'll find everything you need to know from MM&M's April 2017 issue, including our DTC report, our deep dive into respiratory drugs, and more.

PerfectLens sees ROI with programmatic ad buying

PerfectLens sees ROI with programmatic ad buying

The Canadian contact lens etailer partnered with a new technology vendor to look beyond its direct click-to-conversions.

Five things for pharma marketers to know: Monday, April 24, 2017

Five things for pharma marketers to know: Monday, April 24, 2017

QuintilesIMS partners with Salesforce; the E.U. to decide on new EMA location by June; drugmakers boost lobbying dollars in Q1

Purdue Pharma hires new VP of public affairs, communications

Purdue Pharma hires new VP of public affairs, communications

Josephine Martin was previously EVP of public affairs at PhRMA.

Five things for pharma marketers to know: Friday, April 21, 2017

Five things for pharma marketers to know: Friday, April 21, 2017

Teva launches branded competitor to GSK's Advair; Valeant prices psoriasis drug at $3,500 per month; overseas drug importation would save money, op-ed argues

Five things for pharma marketers to know: Thursday, April 20, 2017

Five things for pharma marketers to know: Thursday, April 20, 2017

Tesaro discloses price for new drug that differs from FDA-approved dosage; uniQure discontinues Glybera; O'Reilly leaves Fox

Pharma R&D partnerships are on the rise: report

Pharma R&D partnerships are on the rise: report

This is likely due, in part, to the increasingly complex nature of new specialty drugs.

PhRMA debuts new ads in Go Boldly campaign

PhRMA debuts new ads in Go Boldly campaign

PhRMA worked with WPP Health & Wellness and Young & Rubicam on creative for the ads.

Five things for pharma marketers to know: Wednesday, April 19, 2017

Five things for pharma marketers to know: Wednesday, April 19, 2017

Valeant gave $100,000 to patient group to address affordability of its drug; Omnicom reports 3% increase in specialty group revenue; Verily to study biometric data

J&J blames lower Xarelto and Invokana sales on payer pressure

J&J blames lower Xarelto and Invokana sales on payer pressure

The drugmaker said it has been forced to provide higher rebates to PBMs and insurers for certain drugs.

Five things for pharma marketers to know: Tuesday, April 18, 2017

Five things for pharma marketers to know: Tuesday, April 18, 2017

Novartis gets Breakthrough designation for its CAR-T therapy; Duchesney continues working with Kardashian; new user-fee deal to speed up FDA approvals

Facing a competitive market, Synergy looks to stand out with unbranded emojis

Facing a competitive market, Synergy looks to stand out with unbranded emojis

The drugmaker hopes its emojis will raise awareness about treatment options for constipation.

SPONSORED: Using co-pay programs to acquire and engage patients

SPONSORED: Using co-pay programs to acquire and engage patients

Along with lower costs, effective co-pay offset programs boost patient adherence and better connect with doctors and pharmacies.

Five things for pharma marketers to know: Monday, April 17, 2017

Five things for pharma marketers to know: Monday, April 17, 2017

Kardashian West promotes Diclegis again; drugmakers are developing non-opioid painkillers; healthcare brands test Facebook Live

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

Agency Spotlight

Featured Listings

OPINION

Newsletters